Lakefront Biotherapeutics NV
LKFT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001421876
No open-market purchases or sales by Lakefront Biotherapeutics NV insiders were filed in the last 90 days; 76 institutions reported holding it in 13F filings for Q2 2026, worth $960.3M in total; Greenlight Capital is the only superinvestor holding it.
Other share classesGLPGF
13F holders, Q3 2021
Institutional positions in Lakefront Biotherapeutics NV as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 81
- −27 vs. Q2 2021
- Shares held
- 8.55M
- +1.04M (+13.9%) vs. Q2 2021
- Total value
- $449.8M
- −$67.4M (−13.0%) vs. Q2 2021
- New holders
- 14
- 31 more added
- Sold out
- 41
- 20 more reduced
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LKFT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 76 | $960.3M |
| Q1 2026 | 90 | $937.9M |
| Q4 2025 | 91 | $1.03B |
| Q3 2025 | 92 | $1.09B |
| Q2 2025 | 85 | $887.2M |
| Q1 2025 | 83 | $783.2M |
| Q4 2024 | 82 | $856.9M |
| Q3 2024 | 79 | $393.4M |
| Q2 2024 | 85 | $494.0M |
| Q1 2024 | 83 | $659.6M |
| Q4 2023 | 88 | $804.5M |
| Q3 2023 | 73 | $662.4M |
| Q2 2023 | 76 | $801.4M |
| Q1 2023 | 76 | $703.8M |
| Q4 2022 | 75 | $584.8M |
| Q3 2022 | 84 | $551.1M |
| Q2 2022 | 82 | $720.0M |
| Q1 2022 | 90 | $795.8M |
| Q4 2021 | 83 | $595.0M |
| Q3 2021 | 81 | $449.8M |
| Q2 2021 | 109 | $517.2M |
| Q1 2021 | 133 | $506.0M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Lakefront Biotherapeutics NV; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Capital Asset Advisory Services LLC | 0 | $0 | 0.00% | −5,561−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −4,963−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −3,939−100.0% | Sold out |
| American National Insurance Co | 0 | $0 | 0.00% | −3,500−100.0% | Sold out |
| Moody National Bank Trust Division | 0 | $0 | 0.00% | −3,500−100.0% | Sold out |
| Credit Agricole S A | 0 | $0 | 0.00% | −3,400−100.0% | Sold out |
| Comerica Bank | 0 | $0 | 0.00% | −3,717−100.0% | Sold out |
| FORA Capital, LLC | 0 | $0 | 0.00% | −1,360−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −1,040−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −1,050−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −167−100.0% | Sold out |
| Zions Bancorporation, N.A. | 0 | $0 | 0.00% | −94−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −45−100.0% | Sold out |
| Enterprise Financial Services Corp | 0 | $0 | 0.00% | −28−100.0% | Sold out |
| Accel Wealth Management | 0 | $0 | 0.00% | −22−100.0% | Sold out |
| Eaton Vance Management | 0 | $0 | 0.00% | −21−100.0% | Sold out |
| Column Capital Advisors, LLC | 0 | $0 | 0.00% | −19−100.0% | Sold out |
| Berman Capital Advisors, LLC | 0 | $0 | 0.00% | −22−100.0% | Sold out |
| First Horizon Advisors, Inc. | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Glassman Wealth Services | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| CWM, LLC | – | – | – | – | Not filed |